Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Human complement activation by polygeline and dextran 70

V Videm1, T E Mollnes

  • 1Institute for Surgical Research, Oslo University, National Hospital, Norway.

Scandinavian Journal of Immunology
|March 1, 1994
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Retraction Note: Rifaximin alters gut microbiota profile, but does not affect systemic inflammation - a randomized controlled trial in common variable immunodeficiency.

Scientific reports·2024
Same author

Self-determined motivation and physical activity in patients with rheumatoid arthritis: a cross-sectional study.

Scandinavian journal of rheumatology·2024
Same author

Intracellular Complement Component 3 Attenuated Ischemia-Reperfusion Injury in the Isolated Buffer-Perfused Mouse Heart and Is Associated With Improved Metabolic Homeostasis.

Frontiers in immunology·2022
Same author

Genetic risk score associations for myocardial infarction are comparable in persons with and without rheumatoid arthritis: the population-based HUNT study.

Scientific reports·2020
Same author

Comparison of methods to construct a genetic risk score for prediction of rheumatoid arthritis in the population-based Nord-Trøndelag Health Study, Norway.

Rheumatology (Oxford, England)·2020
Same author

Phagocytosis of live and dead Escherichia coli and Staphylococcus aureus in human whole blood is markedly reduced by combined inhibition of C5aR1 and CD14.

Molecular immunology·2019

Dextran and polygeline, common plasma expanders, activate the complement cascade. This immune response may be relevant in cardiopulmonary bypass and trauma, as expanders counteract inhibitory factors.

Area of Science:

  • Immunology
  • Biochemistry

Background:

  • The complement cascade is implicated in cardiopulmonary bypass (CPB) and trauma.
  • Plasma expanders are frequently used in these clinical scenarios.

Purpose of the Study:

  • To investigate the potential of plasma expanders, specifically dextran 70 and polygeline, to activate the complement system.
  • To assess complement activation under conditions mimicking clinical CPB.

Main Methods:

  • Incubation of fresh human serum with dextran 70 and polygeline.
  • Quantification of C3-activation products and terminal complement complex (TCC) using enzyme immunoassays.
  • Evaluation of complement activation under varying conditions, including serum dilution, heparin presence, and hypothermia.

Main Results:

Related Experiment Videos

  • Dextran 70 induced rapid, dose-dependent C3 activation and TCC formation.
  • High doses of polygeline caused minor complement activation after a delay.
  • Serum dilution enhanced activation by both expanders.
  • Plasma expanders diminished the inhibitory effects of heparin and hypothermia on complement activation.

Conclusions:

  • Dextran 70 and, to a lesser extent, polygeline can activate the complement cascade.
  • These plasma expanders may contribute to complement activation during CPB and in shock treatment.
  • The findings highlight a potential mechanism for adverse immune responses associated with plasma expander use in critical care settings.